GlassScriptPhysician profile
Mallory Allinson
NPI 1043788243
$1,660.48
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $805 · 2022: $856.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $498.11 | 2021-2022 | |
| Daiichi Sankyo INC. | $490.21 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $271.87 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $140.74 | 2021-2022 | |
| Glaxosmithkline, LLC. | $125.00 | 2022 | |
| Genzyme Corporation | $34.81 | 2022 | |
| Pfizer INC. | $29.64 | 2022 | |
| Merck Sharp & Dohme LLC | $23.82 | 2022 | |
| Novartis Pharmaceuticals Corporation | $23.28 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $23.00 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mallory Allinson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.